Replies to post #35434 on NorthWest Biotherapeutics Inc (NWBO)

[PacificNW]

and with all this coverage we are moving up squat...very troubling if you ask me.
We need clarification, I would love Pyrr to totally wrong in his theories. So what does the big giant head say other than regurgitating what Bosch says?

[flipper44]

News coverage is improving somewhat. Besides additional/future results, HE negotiation resolution, FDA expedited phase II trial designations/initiation, enrollment completion and DMC recommendations; large institutional analyst coverage might help. I recently noticed a small biotech that upgraded to NASDAQ started immediately with 6 analysts covering their progress. I trust NWBO management, the board and large investors know when the right time to request coverage is; and I certainly don't know how those wheels get turned, but I'd imagine sooner than later might be a good idea.